A once-a-week Semaglutide injection can mailed directly to your doorstep. Enjoy free consultation, free expedited shipping and careful monitoring from our medical provider
To be eligible, you must have a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related medical condition. Check your BMI index:
https://www.cdc.gov/nccdphp/dnpao/growthcharts/training/bmiage/calc_english.html
Compound Semaglutide with the same active ingredient as Ozempic® / Wegovy® is a once-a-week injection. If you qualify and is prescribed of the medication, then our licensed provider will provide you with a step-by-step instruction on how to properly inject yourself.
Common side effects of Semaglutide include nausea, vomiting, diarrhea, constipation, and decreased appetite. These side effects are usually mild and tend to decrease over time as your body adjusts to the medication.
Randomized placebo-controlled study shows Ozempic® or Wegovy® (Semaglutide) on average lost 5% to 15% over 68 weeks depending on the dosage.
A once-a-week Semaglutide injection can mailed directly to your doorstep. Enjoy free consultation, free expedited shipping and careful monitoring from our medical provider
To be eligible, you must have a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related medical condition. Check your BMI index:
https://www.cdc.gov/nccdphp/dnpao/growthcharts/training/bmiage/calc_english.html
Compound Tirzepaptide the same active ingredient in Mounjaro® / Zepbound® is a once-a-week injection. If you qualify and is prescribed of the medication, then our licensed provider will provide you with a step-by-step instruction on how to properly inject.
Common side effects of Tirzepaptide include nausea, vomiting, diarrhea, constipation, and decreased appetite. These side effects are usually mild and tend to decrease over time as your body adjusts to the medication.
Randomized placebo-controlled study shows Mounjaro® or Zepbound® (Tirzepatide) on average lost 15% to 21% over 72 weeks depending on the dosage.
*Price for a minimum of 3 months of medication purchase. $100 appointment fee is waived, if your medications is paid in full to AVYIA. All medications are made by compounding pharmacies that are fully licensed by State Board of Pharmacy or FDA-licensed 503(b) outsourcing facilities.
Compounded Semaglutide or Tirzepaptide, is not approved or evaluated for safety, efficacy, or quality by FDA. Wegovy® (semaglutide), Ozempic® (semaglutide), Mounjaro® and Zepbound® are not compounded medications and are FDA-approved for weight loss or type 2 diabetes. Weight loss studies of the branded products may not have the same effect as the compounded medication. Talk to your provider if branded or off-label weight loss medication is right for you.
AVYIA’s weight management injections are designed for individuals struggling to lose weight and seek a medically supervised program. Ideal candidates include:
The latest weight loss injections can jumpstart metabolic processes by mimicking a naturally occurring hormone in your body. The medication enhances the body’s ability to suppress appetite and slows down digestion, which tells your brain to feel fuller longer.
Semaglutide found in Ozempic® and Wegovy® is the first class of groundbreaking medication that has been shown to significantly aid in losing weight and long-term use. Here’s an in-depth look at how Semaglutide functions and its effects on your body to promote weight loss:
While Semaglutide is a single GLP-1 receptor agonist, Tirzepatide is a dual agonist for both GLP-1 receptors and gastric inhibitory polypeptide (GIP) receptors. GIP in Tirzepatide enhances lipid metabolism and may help prevent fat accumulation in the liver. Furthermore, GIP may help mitigate the nausea associated with GLP-1 agonists. In other words, Tirzepatide allows for higher therapeutic doses of with fewer adverse effects than Semaglutide.
Studies shows weight loss with Tirzepaptide, which include Mounjaro® and Zepbound™ lost an average of 48 lb or 21% of their body weight at the highest does (15mg), while at the lowest dose (5mg), people lost an average of 34 lb or 15% of their body weight. One in three patients at the highest 15mg dose lost over 58 lb or 25% of their body weight.
Semaglutide, which includes Ozempic® and Wegovy®, on the other hand in comparable studies have resulted in an average weight loss of 15%. In conclusion, research shows Tirzepaptide is currently the best FDA approved weight loss injection.
A 2023 study found that Tirzepatide (Mounjaro®/Zepbound®) is more cost-effective than Semaglutide (Ozempic®/Wegovy®) for weight loss. Despite its higher monthly cost, study shows that Tirzepatide’s cost per 1% body weight reduction is $985, compared to $1845 for Semaglutide. This means Tirzepatide offers better value for those seeking significant weight loss.
AVYIA offers compounded Tirzepatide starting at $269 for the first month. This makes it a more affordable option compared to branded versions like Mounjaro® or Zepbound™, while still being more cost-effective than Semaglutide in terms of weight loss per dollar spent.
AVYIA’s weight loss injections offer numerous benefits in addition to simply lose weight, individuals struggling with obesity or overweight conditions that include the following:
Weight loss injections can help improve blood sugar control and increase insulin sensitivity, significantly reducing the risk of developing type 2 diabetes in individuals with prediabetes or managing existing diabetes more effectively
Weight loss associated with these injections can lead to improvements in cardiovascular health, including lower blood pressure, reduced cholesterol levels, and a decrease in arterial stiffness, which can reduce the risk of heart disease and stroke
These medications often improve various metabolic markers, including blood lipids and liver enzymes, which can reduce the risk of fatty liver disease and other metabolic syndromes
Obesity is often associated with increased inflammation in the body, which can contribute to several chronic diseases. Weight loss can help decrease systemic inflammation
Drugs like Semaglutide and Tirzepatide work by mimicking a hormone that regulates appetite and satiety, leading to reduced calorie intake and significant weight loss
Weight loss can significantly enhance physical mobility and reduce joint pain, making physical activity more comfortable and accessible
Effective weight management can improve mood, reduce symptoms of depression and anxiety, and boost overall quality of life
Weight loss can improve or even resolve conditions like obstructive sleep apnea, which is more common in individuals with higher body weight
AVYIA makes it easy and convenient to start your journey. Here’s a 1-2-3 guide on how to get prescription for both name brands or compounded weight loss injections:
Begin by booking a consultation with one of AVYIA’s healthcare professionals. This can be done directly through our website. We will discuss your weight loss goals, medical history, conduct medical evaluation and any current health issues
If Semaglutide or Tirzepatide is deemed suitable for you, our provider will prescribe the medication to you. AVYIA ensures that the process is compliant with all medical regulations and standards to guarantee your safety and the effectiveness of your treatment.
AVYIA will refer you to pharmacies to have your medication shipped directly to your home. Our reliable mail-order pharmacy service ensures that you receive your medication quickly and discreetly and we will coach you how to safely administer it yourself
AVYIA provides continuous support, refills and monitoring to help you achieve the best possible results. This includes follow-up consultations to assess your progress, adjust your dosages, and provide guidance on diet, exercise, and healthy lifestyle changes if necessary
